PDLIM2 and lung carcinoma: Remarkably, clinically feasible nano-delivery of PDLIM2 (nanoPDLIM2) shows a promising efficacy as a monotherapy, and in combination with ICIs and chemo drugs, completely eradicates all tumors in most animals without adding toxicity, in the preclinical model of refractory lung cancer (21, 31).